8-K Announcements
6Material company update
May 4, 2026·SEC
Material company update
Mar 3, 2026·SEC
Material company update
Nov 4, 2025·SEC
Cryoport, Inc.(CYRX)Earnings, Financials & Key Ratios
CYRX•NASDAQ
10.7× P/E·Price updated Jun 19, 2026
SectorIndustrialsIndustryFreight & LogisticsSub-IndustryContract Logistics and Specialized Warehousing
AboutCryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.Show more
- Revenue$176M-24.5%
- EBITDA-$12M+86.7%
- Net Income$70M+170.6%
- EPS (Diluted)1.40+163.3%
- Gross Margin47.14%+10.7%
- EBITDA Margin-6.61%+82.4%
- Operating Margin-20.89%+57.7%
- Net Margin39.9%+193.5%
- ROE15.54%+169.5%
CYRX Key Insights
Cryoport, Inc. (CYRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 92 (top 8%)
- ✓Strong 5Y sales CAGR of 17.5%
- ✓Trading at only 1.5x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CYRX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CYRX Price & Volume
Cryoport, Inc. (CYRX) stock price & volume — 10-year historical chart
Loading chart...
CYRX Growth Metrics
Cryoport, Inc. (CYRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years40.49%
5 Years17.49%
3 Years-7.5%
TTM-7.11%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM171.53%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM160.26%
Return on Capital
10 Years-30.81%
5 Years-5.67%
3 Years-8.13%
Last Year-6.21%
CYRX Recent Earnings
Cryoport, Inc. (CYRX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 4, 2026Metric
Actual
Est
EPS
$0.23-15.0%
$0.20
Rev
$48M+6.5%
$45M
Q2 2026
Mar 3, 2026Metric
Actual
Est
EPS
$0.21-10.5%
$0.19
Rev
$45M+6.1%
$43M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.18+21.7%
$0.23
Rev
$44M+3.0%
$43M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.29-45.0%
$0.20
Rev
$45M+9.4%
$42M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $0.23vs $0.20-15.0% | $48Mvs $45M+6.5% |
| Q2 2026 | Mar 3, 2026 | $0.21vs $0.19-10.5% | $45Mvs $43M+6.1% |
| Q4 2025 | Nov 4, 2025 | $0.18vs $0.23+21.7% | $44Mvs $43M+3.0% |
| Q3 2025 | Aug 5, 2025 | $0.29vs $0.20-45.0% | $45Mvs $42M+9.4% |
Based on last 12 quarters of dataView full earnings history →
CYRX Peer Comparison
Cryoport, Inc. (CYRX) competitors in Contract Logistics and Specialized Warehousing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LQDA | 6.32B | 71.07 | -88.84 | 10.31% | 7.74% | 46.82% | 4.42 | |
 FWRD | 430.73M | 13.62 | -3.91 | 0.84% | -3.71% | -52.57% | 13.36 | |
 XPOF | 254.84M | 6.83 | -4.65 | -1.71% | -11.1% | |||
 IART | 1.37B | 17.58 | -2.61 | 1.53% | -30.15% | -47.65% | 1.95 | |
 UPS | 89.22B | 105.00 | 16.01 | -2.49% | 5.94% | 32.98% | 1.99 | |
 FDX | 77.83B | 326.20 | 19.41 | 0.27% | 4.88% | 15.76% | 1.33 | |
 CHRW | 21.95B | 185.04 | 38.31 | -8.42% | 3.7% | 33.32% | 0.88 | |
 XPO | 23.42B | 199.50 | 75.57 | 1.05% | 4.19% | 19.04% | 2.53 |
Compare CYRX vs Peers
Cryoport, Inc. (CYRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CYRX Income Statement
Cryoport, Inc. (CYRX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 11.95M | 19.63M | 33.94M | 78.7M | 222.61M | 222.61M | 237.28M | 233.25M | 176.18M | 182.94M |
Revenue Growth % | 55.68% | 64.18% | 72.94% | 131.85% | 182.87% | 0% | 6.59% | -1.7% | -24.47% | -7.11% |
Cost of Goods Sold | 5.99M | 9.39M | 16.59M | 42.36M | 126.03M | 126.03M | 133.4M | 133.92M | 93.12M | 96.61M |
COGS % of Revenue | 50.09% | 47.82% | 48.88% | 53.83% | 56.62% | 56.62% | 56.22% | 57.41% | 52.86% | - |
Gross Profit | 5.97M▲ 0% | 10.24M▲ 71.6% | 17.35M▲ 69.4% | 36.33M▲ 109.4% | 96.58M▲ 165.8% | 96.58M▲ 0.0% | 103.87M▲ 7.6% | 99.33M▼ 4.4% | 83.05M▼ 16.4% | 86.33M▲ 0% |
Gross Margin % | 49.91% | 52.18% | 51.12% | 46.17% | 43.38% | 43.38% | 43.78% | 42.59% | 47.14% | 47.19% |
Gross Profit Growth % | 92.38% | 71.63% | 69.45% | 109.39% | 165.8% | 0% | 7.55% | -4.37% | -16.39% | - |
Operating Expenses | 13.86M | 18.88M | 35.03M | 66.34M | 114.41M | 114.41M | 135.78M | 214.49M | 119.86M | 123.26M |
OpEx % of Revenue | 115.93% | 96.22% | 103.2% | 84.3% | 51.39% | 51.39% | 57.22% | 91.95% | 68.03% | - |
Selling, General & Admin | 12.65M | 17.04M | 31.29M | 56.86M | 97.56M | 97.56M | 120.06M | 146.88M | 102.82M | 108.54M |
SG&A % of Revenue | 105.85% | 86.84% | 92.17% | 72.25% | 43.83% | 43.83% | 50.6% | 62.97% | 58.36% | - |
Research & Development | 1.21M | 1.84M | 3.74M | 9.48M | 16.84M | 16.84M | 15.72M | 18.04M | 17.04M | 17.01M |
R&D % of Revenue | 10.09% | 9.38% | 11.02% | 12.05% | 7.57% | 7.57% | 6.63% | 7.73% | 9.67% | - |
Other Operating Expenses | 14.34K | 77.63K | 0 | 0 | 0 | 0 | 0 | 49.57M | 0 | -1000K |
Operating Income | -7.89M▲ 0% | -8.64M▼ 9.5% | -17.68M▼ 104.5% | -30.01M▼ 69.8% | -17.83M▲ 40.6% | -17.83M▲ 0.0% | -31.9M▼ 78.9% | -115.16M▼ 260.9% | -36.81M▲ 68.0% | -36.94M▲ 0% |
Operating Margin % | -66.02% | -44.05% | -52.07% | -38.13% | -8.01% | -8.01% | -13.45% | -49.37% | -20.89% | -20.19% |
Operating Income Growth % | 9.97% | -9.53% | -104.46% | -69.79% | 40.59% | 0% | -78.94% | -260.95% | 68.04% | - |
EBITDA | -7.23M | -7.79M | -15.26M | -20.14M | 2.42M | 2.42M | -9.14M | -87.67M | -11.65M | -10.47M |
EBITDA Margin % | -60.46% | -39.67% | -44.96% | -25.59% | 1.09% | 1.09% | -3.85% | -37.59% | -6.61% | -5.72% |
EBITDA Growth % | 13.87% | -7.73% | -95.98% | -31.99% | 112.01% | 0% | -477.96% | -859.3% | 86.71% | 87.96% |
D&A (Non-Cash Add-back) | 664.83K | 857.94K | 2.42M | 9.87M | 20.25M | 20.25M | 22.77M | 27.49M | 25.15M | 26.47M |
EBIT | -7.88M | -9.47M | -16.9M | -30.18M | -269.15M | -269.15M | -28.95M | -93.84M | -36.81M | -36.77M |
Net Interest Income | -15.69K | -69.25K | -1.37M | -2.56M | -4.69M | -4.69M | -6.14M | -5.5M | 7.44M | 7.64M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.8M | 9.85M |
Interest Expense | 15.69K | 69.25K | 1.37M | 2.56M | 4.69M | 4.69M | 6.14M | 5.5M | 2.36M | 2.21M |
Other Income/Expense | -1.36K | -891.03K | -595K | -2.73M | -256.01M | -256.01M | -3.19M | 15.81M | 4.64M | 4.24M |
Pretax Income | -7.89M▲ 0% | -9.54M▼ 20.8% | -18.27M▼ 91.6% | -32.74M▼ 79.2% | -273.84M▼ 736.5% | -273.84M▲ 0.0% | -35.09M▲ 87.2% | -99.35M▼ 183.1% | -32.17M▲ 67.6% | -32.7M▲ 0% |
Pretax Margin % | -66.03% | -48.59% | -53.83% | -41.6% | -123.02% | -123.02% | -14.79% | -42.59% | -18.26% | -17.88% |
Income Tax | 5.14K | 19.95K | 62K | -45K | 1.69M | 1.69M | 2.24M | 239K | 1.8M | 1.67M |
Effective Tax Rate % | -0.07% | -0.21% | -0.34% | 0.14% | -0.62% | -0.62% | -6.38% | -0.24% | -5.59% | -5.12% |
Net Income | -7.9M▲ 0% | -9.56M▼ 21.0% | -18.33M▼ 91.8% | -32.69M▼ 78.3% | -275.53M▼ 742.8% | -275.53M▲ 0.0% | -37.33M▲ 86.5% | -99.59M▼ 166.8% | 70.3M▲ 170.6% | 77.14M▲ 0% |
Net Margin % | -66.08% | -48.69% | -54.01% | -41.54% | -123.77% | -123.77% | -15.73% | -42.69% | 39.9% | 42.17% |
Net Income Growth % | 39.76% | -20.97% | -91.85% | -78.34% | -742.77% | 0% | 86.45% | -166.75% | 170.59% | 171.53% |
Net Income (Continuing) | -7.9M | -9.56M | -18.33M | -32.69M | -275.53M | -275.53M | -37.33M | -99.59M | -33.97M | -34.37M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.68M | 724K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.34▲ 0% | -0.34▲ 0.0% | -0.55▼ 61.8% | -1.94▼ 252.7% | -6.18▼ 218.6% | -6.18▲ 0.0% | -0.93▲ 85.0% | -2.21▼ 137.6% | 1.40▲ 163.3% | 1.55▲ 0% |
EPS Growth % | 63.04% | 0% | -61.76% | -252.73% | -218.56% | 0% | 84.95% | -137.63% | 163.35% | 160.26% |
EPS (Basic) | -0.34 | -0.34 | -0.55 | -1.94 | -6.18 | -6.18 | -0.93 | -2.21 | 1.40 | - |
Diluted Shares Outstanding | 22.96M | 28.21M | 33.39M | 38.58M | 45.93M | 45.93M | 48.99M | 48.74M | 50.07M | 49.9M |
Basic Shares Outstanding | 22.96M | 28.21M | 33.39M | 38.58M | 45.93M | 45.93M | 48.99M | 48.74M | 50.07M | 49.9M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
CYRX Balance Sheet
Cryoport, Inc. (CYRX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 17.3M | 51.77M | 102.97M | 147.16M | 693.52M | 604.18M | 535.11M | 341.57M | 476.17M | 470.54M |
Cash & Short-Term Investments | 15.04M | 47.26M | 94.3M | 93.32M | 628.8M | 523.32M | 456.75M | 261.75M | 411.21M | 403.63M |
Cash Only | 15.04M | 37.33M | 47.23M | 36.87M | 139.1M | 36.59M | 46.35M | 45.29M | 250.49M | 272.91M |
Short-Term Investments | 0 | 9.93M | 47.06M | 56.44M | 489.7M | 486.73M | 410.41M | 216.46M | 160.71M | 130.72M |
Accounts Receivable | 1.63M | 3.54M | 7.1M | 31.38M | 39.41M | 43.86M | 42.07M | 45.78M | 33.36M | 39M |
Days Sales Outstanding | 49.63 | 65.9 | 76.33 | 145.53 | 64.62 | 71.91 | 64.72 | 71.63 | 69.11 | 67.66 |
Inventory | 114.8K | 220.51K | 474K | 10.54M | 16.5M | 27.68M | 26.21M | 22.47M | 23.19M | 21.75M |
Days Inventory Outstanding | 7 | 8.58 | 10.43 | 90.77 | 47.79 | 80.16 | 71.7 | 61.24 | 90.89 | 86.52 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 9.32M | 10.08M | 11.57M | 8.42M | 6.15M |
Total Non-Current Assets | 2.97M | 4.85M | 32.91M | 405.25M | 419.45M | 434.57M | 422.63M | 361.92M | 288.81M | 293.07M |
Property, Plant & Equipment | 2.51M | 4.36M | 16.29M | 44.08M | 69.7M | 90.48M | 117.51M | 136.03M | 125.17M | 129.1M |
Fixed Asset Turnover | 4.76x | 4.50x | 2.08x | 1.79x | 3.19x | 2.46x | 2.02x | 1.71x | 1.41x | 1.47x |
Goodwill | 0 | 0 | 11M | 145.28M | 146.95M | 151.12M | 108.4M | 51.66M | 22.4M | 22.14M |
Intangible Assets | 90.65K | 137.22K | 5.18M | 213.91M | 201.43M | 191.01M | 194.38M | 170.46M | 138.08M | 138.72M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 363.4K | 350.84K | 437K | 1.98M | 950K | 1.02M | 1.68M | 2.9M | 2.09M | 2.05M |
Total Assets | 20.26M▲ 0% | 56.62M▲ 179.4% | 135.87M▲ 140.0% | 552.4M▲ 306.6% | 1.11B▲ 101.5% | 1.04B▼ 6.7% | 957.74M▼ 7.8% | 703.49M▼ 26.5% | 764.99M▲ 8.7% | 763.61M▲ 0% |
Asset Turnover | 0.59x | 0.35x | 0.25x | 0.14x | 0.20x | 0.21x | 0.25x | 0.33x | 0.23x | 0.24x |
Asset Growth % | 149.81% | 179.41% | 139.97% | 306.56% | 101.48% | -6.67% | -7.8% | -26.55% | 8.74% | 10.3% |
Total Current Liabilities | 2.19M | 3.06M | 5.46M | 35.02M | 42.65M | 40.85M | 45.61M | 64.56M | 219.02M | 224.87M |
Accounts Payable | 1.2M | 1.64M | 2.5M | 24.84M | 28.58M | 27.05M | 26.05M | 26.17M | 15.28M | 15.94M |
Days Payables Outstanding | 73.35 | 63.91 | 54.96 | 214.06 | 82.78 | 78.33 | 71.29 | 71.32 | 59.9 | 55.3 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 60K | 149K | 14.44M | 189.81M | 189.61M |
Deferred Revenue (Current) | 0 | 66.31K | 368K | 445K | 547K | 439K | 1.31M | 1.11M | 943K | 6.48M |
Other Current Liabilities | 56.27K | 0 | 518K | 1.39M | 1.91M | 3.45M | 3.8M | 3.71M | 12.98M | 0 |
Current Ratio | 7.92x | 16.91x | 18.85x | 4.20x | 16.26x | 14.79x | 11.73x | 5.29x | 2.17x | 2.09x |
Quick Ratio | 7.86x | 16.84x | 18.77x | 3.90x | 15.88x | 14.11x | 11.16x | 4.94x | 2.07x | 2.00x |
Cash Conversion Cycle | -16.72 | 10.57 | 31.8 | 22.24 | 29.63 | 73.74 | 65.14 | 61.56 | 100.1 | 98.89 |
Total Non-Current Liabilities | 192.2K | 15.01M | 4.13M | 134.69M | 428.5M | 442.06M | 423.11M | 237.03M | 43.33M | 43.75M |
Long-Term Debt | 0 | 14.71M | 0 | 116.26M | 405.26M | 407.06M | 379.89M | 185.03M | 1.09M | 1.03M |
Capital Lease Obligations | 0 | 33.16K | 4.11M | 12.37M | 18.2M | 24.94M | 30.31M | 45.32M | 39.82M | 158.75M |
Deferred Tax Liabilities | 0 | 0 | 21K | 5.88M | 4.02M | 4.93M | 2.82M | 2.53M | 1.35M | 4.48M |
Other Non-Current Liabilities | 192.2K | 267.42K | 0 | 176K | 1.03M | 5.13M | 10.1M | 4.14M | 1.07M | 1.29M |
Total Liabilities | 2.38M | 18.07M | 9.59M | 169.71M | 471.14M | 482.91M | 468.72M | 301.59M | 262.35M | 268.62M |
Total Debt | 0 | 14.77M | 4.8M | 130.92M | 427.06M | 435.91M | 416M | 250.7M | 230.72M | 230.49M |
Net Debt | -15.04M | -22.56M | -42.43M | 94.05M | 287.95M | 399.31M | 369.66M | 205.41M | -19.78M | -42.42M |
Debt / Equity | - | 0.38x | 0.04x | 0.34x | 0.67x | 0.78x | 0.85x | 0.62x | 0.46x | 0.47x |
Debt / EBITDA | - | - | - | - | 176.61x | 180.28x | - | - | - | -22.02x |
Net Debt / EBITDA | - | - | - | - | 119.09x | 165.14x | - | - | - | 4.05x |
Interest Coverage | -502.02x | -136.69x | -12.37x | -11.79x | -57.40x | -57.40x | -4.71x | -17.05x | -15.59x | -16.64x |
Total Equity | 17.89M▲ 0% | 38.55M▲ 115.5% | 126.28M▲ 227.6% | 382.7M▲ 203.1% | 641.83M▲ 67.7% | 555.84M▼ 13.4% | 489.02M▼ 12.0% | 401.9M▼ 17.8% | 502.64M▲ 25.1% | 494.99M▲ 0% |
Equity Growth % | 214.89% | 115.5% | 227.61% | 203.05% | 67.71% | -13.4% | -12.02% | -17.82% | 25.07% | 71.49% |
Book Value per Share | 0.78 | 1.37 | 3.78 | 9.92 | 13.97 | 12.10 | 9.98 | 8.25 | 10.04 | 9.92 |
Total Shareholders' Equity | 17.89M | 38.55M | 126.28M | 382.7M | 641.83M | 555.84M | 489.02M | 401.9M | 502.64M | 494.99M |
Common Stock | 25.7K | 30.32K | 37K | 40K | 50K | 48K | 49K | 50K | 50K | 0 |
Retained Earnings | -131.43M | -140.99M | -159.32M | -192.01M | -467.54M | -542.83M | -642.42M | -757.17M | -688.88M | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 3.15K | -45K | 5.38M | -1.24M | -34.55M | -26.07M | -20.93M | -3.48M | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CYRX Cash Flow Statement
Cryoport, Inc. (CYRX) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -3.58M | -3.35M | -1.32M | -14.87M | 8.13M | -1.85M | -757K | -16.32M | -8.58M | -4.24M |
Operating CF Margin % | -29.97% | -17.08% | -3.9% | -18.89% | 3.65% | -0.83% | -0.32% | -7% | -4.87% | - |
Operating CF Growth % | 37.35% | 6.44% | 60.51% | -1022.81% | 154.66% | -122.78% | 59.1% | -2056.27% | 47.44% | 614.73% |
Net Income | -7.9M | -9.56M | -18.33M | -32.69M | -275.53M | -37.33M | -99.59M | -114.76M | 78.3M | 77.14M |
Depreciation & Amortization | 664.83K | 857.94K | 2.42M | 9.87M | 20.25M | 22.77M | 27.49M | 30.76M | 27.71M | 26.47M |
Stock-Based Compensation | 3.55M | 5.48M | 16.52M | 8.92M | 15.35M | 20.08M | 22.81M | 19.7M | 11.03M | 4.96M |
Deferred Taxes | 197.68K | 453.92K | 0 | 858K | 253.79M | 0 | -1.98M | 0 | 0 | 1.1M |
Other Non-Cash Items | 6.13K | 899.41K | 1.04M | 437K | 1.24M | 24.7M | 49.73M | 56.58M | -111.93M | 13.31M |
Working Capital Changes | -100.54K | -1.49M | -2.97M | -2.25M | -6.96M | -32.07M | 780K | -8.61M | -13.69M | -13.73M |
Change in Receivables | -441.64K | -1.96M | -3.6M | -2.62M | -7.27M | -4.14M | 3.67M | -4.15M | -6.53M | -7.3M |
Change in Inventory | -25.3K | -105.72K | -253K | 1.32M | -5.98M | -14.2M | 1.51M | 3.25M | -2.19M | 120K |
Change in Payables | 123.25K | 405.07K | 570.48K | 4.25M | 2.87M | -6.48M | -2.77M | -76K | -3.46M | -2.68M |
Cash from Investing | -1.8M | -12.88M | -62.93M | -382.31M | -469.25M | -59.68M | 36.05M | 176.81M | 250.32M | 244.4M |
Capital Expenditures | -1.71M | -2.91M | -5.34M | -8.92M | -23.88M | -22.11M | -38.78M | -17.25M | -16.44M | -15.12M |
CapEx % of Revenue | 14.35% | 14.85% | 15.72% | 11.33% | 10.73% | 9.93% | 16.35% | 7.4% | 9.33% | 8.27% |
Acquisitions | 0 | 0 | -20.32M | -363.14M | -5.54M | -6.55M | -7.34M | 0 | 210.24M | 210.24M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -85.65K | -46.57K | -73K | -751K | -1.13M | 910K | -5.14M | -4.33M | -3.07M | -306K |
Cash from Financing | 15.9M | 38.53M | 74.15M | 385.58M | 564.34M | -39.17M | -23.8M | -161.53M | -21.07M | -20.89M |
Debt Issued (Net) | -656.22K | 14.99M | -23K | 114.93M | 36.61M | -3.26M | -25.28M | -164.32M | -15.04M | -14.84M |
Equity Issued (Net) | 16.56M | 23.83M | 74.17M | 274.77M | 527.73M | -35.91M | 1.48M | 2.79M | -6.04M | -6.04M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | -37.96M | 0 | 0 | -10.01M | -10.01M |
Other Financing | 0 | 0 | 0 | -4.12M | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change in Cash | 10.52M▲ 0% | 22.28M▲ 111.9% | 9.91M▼ 55.5% | -10.36M▼ 204.6% | 102.23M▲ 1086.6% | -102.51M▼ 200.3% | 9.75M▲ 109.5% | -1.06M▼ 110.8% | 205.21M▲ 19513.9% | 236.81M▲ 0% |
Free Cash Flow | -5.38M▲ 0% | -6.31M▼ 17.3% | -6.73M▼ 6.7% | -24.54M▼ 264.4% | -16.88M▲ 31.2% | -26.05M▼ 54.3% | -45.66M▼ 75.3% | -33.58M▲ 26.5% | -28.09M▲ 16.4% | -17.82M▲ 0% |
FCF Margin % | -45.04% | -32.17% | -19.84% | -31.18% | -7.58% | -11.7% | -19.24% | -14.39% | -15.94% | -9.74% |
FCF Growth % | 20.67% | -17.26% | -6.65% | -264.4% | 31.2% | -54.3% | -75.28% | 26.46% | 16.36% | 48.19% |
FCF per Share | -0.23 | -0.22 | -0.20 | -0.64 | -0.37 | -0.57 | -0.93 | -0.69 | -0.56 | -0.36 |
FCF Conversion (FCF/Net Income) | 0.45x | 0.35x | 0.07x | 0.45x | -0.03x | 0.01x | 0.02x | 0.16x | -0.12x | -0.23x |
Interest Paid | 4.74K | 637 | 707K | 1.82M | 3.3M | 3.63M | 3.4M | 2.69M | 0 | 743K |
Taxes Paid | 5.14K | 19.95K | 14K | 60K | 1.31M | 1.98M | 1.46M | 1.42M | 0 | 1.97M |
CYRX Key Ratios
Cryoport, Inc. (CYRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -67.03% | -33.87% | -22.24% | -12.85% | -53.79% | -46.01% | -7.15% | -22.36% | 15.54% | 16.16% |
Return on Invested Capital (ROIC) | -301.28% | -68.86% | -26.56% | -8.03% | -1.9% | -1.42% | -2.64% | -11.78% | -5.06% | -5.46% |
Gross Margin | 49.91% | 52.18% | 51.12% | 46.17% | 43.38% | 43.38% | 43.78% | 42.59% | 47.14% | 47.19% |
Net Margin | -66.08% | -48.69% | -54.01% | -41.54% | -123.77% | -123.77% | -15.73% | -42.69% | 39.9% | 42.17% |
Debt / Equity | - | 0.38x | 0.04x | 0.34x | 0.67x | 0.78x | 0.85x | 0.62x | 0.46x | 0.47x |
Interest Coverage | -502.02x | -136.69x | -12.37x | -11.79x | -57.40x | -57.40x | -4.71x | -17.05x | -15.59x | -16.64x |
FCF Conversion | 0.45x | 0.35x | 0.07x | 0.45x | -0.03x | 0.01x | 0.02x | 0.16x | -0.12x | -0.23x |
Revenue Growth | 55.68% | 64.18% | 72.94% | 131.85% | 182.87% | 0% | 6.59% | -1.7% | -24.47% | -7.11% |
Related:CYRX Dividend History·CYRX Revenue History·CYRX Price History·CYRX P/E History·CYRX Financial Ratios·CYRX Institutional Holders
CYRX SEC Filings & Documents
Cryoport, Inc. (CYRX) SEC filings — annual & quarterly reports (10-K, 10-Q)
CYRX Frequently Asked Questions
Cryoport, Inc. (CYRX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cryoport, Inc. (CYRX) reported $182.9M in revenue for fiscal year 2025. This represents a 67297% increase from $0.3M in 2003.
Cryoport, Inc. (CYRX) saw revenue decline by 24.5% over the past year.
Yes, Cryoport, Inc. (CYRX) is profitable, generating $77.1M in net income for fiscal year 2025 (39.9% net margin).
Dividend & Returns
Cryoport, Inc. (CYRX) has a return on equity (ROE) of 15.5%. This is reasonable for most industries.
Cryoport, Inc. (CYRX) had negative free cash flow of $17.8M in fiscal year 2025, likely due to heavy capital investments.